EPINEPHRINE INJECTION

The Defense Logistics Agency issued a delivery order under the master contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the procurement of two units of EPINEPHRINE INJECTION, identified by NSN 6505015273957, at a unit price of $93.33, resulting in a total contract value of $186.66. The order was awarded on July 14, 2026, with a mandatory delivery date of July 29, 2026, to the destination at Fort Stewart, Georgia. The delivery terms are FOB Destination, placing responsibility on the contractor for safe transit and delivery, with inspection and acceptance performed by the government upon arrival. The item is a commercial off-the-shelf pharmaceutical, and the award reflects a low-value, non-complex transaction driven primarily by price, indicative of a Low-Price Technically Acceptable approach. The contracting officer, Lisa Quinn, is the point of contact, with no assigned Contracting Officer’s Representative. Payment will be processed through DEF FIN AND ACCOUNTING SVC, BSM, using voucher-based verification, with remittance sent to P.O. Box 182317, Columbus, OH. The contractor certified as a Small Business, Small Disadvantaged Business, and Women-Owned Business, triggering compliance obligations under FAR 19.7, 19.14, and 19.15. Packaging must follow traceable shipping methods without use of parcel post, and all items must be marked with the assigned traceable control number W33RBS61950341. No specific MIL-STD packaging standards, detailed quality specifications, or explicit FAR/DFARS contract clauses were included in the documentation. The delivery order contains no options, modifications, or special requirements beyond the core supply delivery, and no evaluation factors, technical criteria, or administrative attachments were provided, underscoring its transactional nature under a broader multiple-award vehicle.